Natco successfully opposes patent application
Hyderabad-based Natco Pharma limited said that it had successfully opposed a patent application in India that covers the composition of Glatiramer Acetate, the generic version of Teva Pharmaceutical Industries Copaxone.
Boston Scientific, Natick, Mass., has been assigned a patent developed by John Mon, Silver Spring, Md., and Alan J. Fenn, Wayland, Mass., for a drug delivery.